about
Reactive oxygen species and mitochondria: A nexus of cellular homeostasisStaphylococcal response to oxidative stressAntimicrobial strategies centered around reactive oxygen species--bactericidal antibiotics, photodynamic therapy, and beyondAnti-Immune Strategies of Pathogenic FungiLow serum myeloperoxidase in autistic children with gastrointestinal diseaseA possible link between iron deficiency and gastrointestinal carcinogenesis.The role of neutrophil myeloperoxidase in models of lung tumor development.Genetic control of susceptibility to infection with Candida albicans in mice.Lactoperoxidase. New recognition of an "old" enzyme in airway defenses.Growing significance of myeloperoxidase in non-infectious diseases.Influence of DMT1 and iron status on inflammatory responses in the lungHuman polymorphonuclear neutrophils specifically recognize and kill cancerous cells.Decreased plasma myeloperoxidase associated with probiotic therapy in autistic children.Systemic disease and periodontitis: manifestations of neutrophil dysfunction.Myeloperoxidase propagates damage and is a potential therapeutic target for subacute stroke.Antimicrobial actions of reactive oxygen speciesInfections in patients with inherited defects in phagocytic function.Genetic analysis of innate immunity in resistance to Candida albicans.Demyelinating diseases: myeloperoxidase as an imaging biomarker and therapeutic target.Influence of myeloperoxidase on colon tumor occurrence in inflamed versus non-inflamed colons of Apc(Min/+) miceNox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy.Myeloperoxidase-Hepatocyte-Stellate Cell Cross Talk Promotes Hepatocyte Injury and Fibrosis in Experimental Nonalcoholic SteatohepatitisRelationship between glycemic control and histochemical myeloperoxidase activity in neutrophils in patients with type 2 diabetesAugmented inducible nitric oxide synthase expression and increased NO production reduce sepsis-induced lung injury and mortality in myeloperoxidase-null mice.Myeloperoxidase Attenuates Pathogen Clearance during Plasmodium yoelii Nonlethal Infection.Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis.Immune defence against Candida fungal infections.Myeloperoxidase targets oxidative host attacks to Salmonella and prevents collateral tissue damage.Evaluation of canine red blood cell quality after processing with an automated cell salvage device.Increased myeloperoxidase index and large unstained cell values can predict the neutropenia phase of cancer patients treated with standard dose chemotherapy.Myeloperoxidase deficiency: the secret under the flag of unstained cellMyeloperoxidase Inhibition Increases Neurogenesis after Ischemic Stroke.Genetic control of susceptibility to Candida albicans in susceptible A/J and resistant C57BL/6J mice.Ceruloplasmin and myeloperoxidase in complex affect the enzymatic properties of each other.Multiple Brain Abscesses Caused by Trichosporon inkin in a Patient with X-Linked Chronic Granulomatous Disease (CGD) Successfully Treated with Antifungal Therapy.The Role of IL-17 in Protection against Mucosal Candida Infections.The chlorinated lipidome originating from myeloperoxidase-derived HOCl targeting plasmalogens: Metabolism, clearance, and biological properties.[The myeloperoxidase: a fine strategist facing pathogenic infections].Analysis of myeloperoxidase activity in wound fluids as a marker of infection.Myeloperoxidase Levels and Its Product 3-Chlorotyrosine Predict Chronic Kidney Disease Severity and Associated Coronary Artery Disease.
P2860
Q26782529-F05D3C4C-3D94-4B11-B566-1790775C02A0Q26991866-6DFC76AD-A3E9-48C3-9DDF-40BFCD2F8D51Q27001203-F0F10074-9DD4-40AA-A885-5FD578F3E833Q28071716-63FBD153-7B89-472A-A3F3-E56AF7BBD10DQ28241398-39BF1E08-AF1B-4669-A799-4B78A02D5BB7Q33511275-1B50DAEB-6068-4A4D-B611-796AF00C7C9DQ33820306-CD56F3EC-7202-4D15-9D98-D451C94D74ACQ33886289-C1895089-9823-4868-B28C-2BBE1F2CEB1DQ33933051-7791E193-3B55-4936-AD43-FEEBF411E8C5Q34578402-4B2E4236-1549-4307-88F7-94D884A6CC59Q34784937-58E18CCE-FA55-4C53-8025-15E74E05B426Q34931766-CED7C210-124F-40AA-B3C1-BEC72455D0BAQ35057148-86874C37-D058-474B-BA74-A4082714D6D8Q35130973-4076EA00-984F-423A-AA42-A21FA2C9CC99Q35143525-A1280F23-3727-4120-BB77-A790A6C58C74Q35210323-2C8EA840-2DB9-42C4-A323-BF004B2F321DQ35558806-71176AC2-3B96-4021-9053-16D7A205170EQ35889577-8E23F376-D616-4548-A87C-65E7C26735AAQ35896745-332E89F5-E845-4446-A5E0-50FE710C1892Q35952680-A28F7EF0-33FD-489F-8C50-200830FAF374Q36052377-DC4901E9-1F74-4F12-9900-A0DE793169ABQ36367829-DC91A351-1487-4D0B-946F-72F5BD749095Q36417045-219FA3E8-93FE-4EA8-B7A3-6F48262FE95DQ36808024-3E5A9EA0-D765-4E6F-A474-FF67EB2425B5Q37546933-FF877C43-8BC3-4DC3-8A25-33204FCB0665Q37624083-68DA43C7-2CCC-45AD-9AEB-BFE9A564383FQ38590007-6539D27E-A0CE-4392-9CB3-841D7C48EE7FQ39005654-AA511586-B502-4865-84DB-2AA24A3B9A9DQ39850730-959BC8F3-5B93-4FEF-842B-3AC03C3951C7Q40604275-1C6FE695-56F9-48C3-81C3-B9C8318263B7Q41846409-0DF948DB-251A-42FF-BB35-0E1A71DA3E19Q42713287-F1CE8C83-23D4-4DEB-A968-FED8433E9BBDQ44115977-15C36319-AD19-4C9D-808B-96955A39A864Q46230315-24B79270-E6DB-48A0-83BC-A233FDC92ACFQ47830037-59D6EFE5-0A4E-446C-9AB8-8516DB550F72Q49184561-555A994F-A930-47B7-9EC3-A7F6991053CDQ49603161-17EBCF78-8EB0-45C3-B082-6639FB62AD12Q49845791-30B34EF4-62B3-4B84-9A8C-212CFA785CACQ50237056-8E2261A5-D26F-4CB1-B03C-9F83FB67BD98Q50912369-E5575346-D015-4A32-AF61-0AF0691C7DEB
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Clinical manifestation of myeloperoxidase deficiency.
@ast
Clinical manifestation of myeloperoxidase deficiency.
@en
Clinical manifestation of myeloperoxidase deficiency.
@nl
type
label
Clinical manifestation of myeloperoxidase deficiency.
@ast
Clinical manifestation of myeloperoxidase deficiency.
@en
Clinical manifestation of myeloperoxidase deficiency.
@nl
prefLabel
Clinical manifestation of myeloperoxidase deficiency.
@ast
Clinical manifestation of myeloperoxidase deficiency.
@en
Clinical manifestation of myeloperoxidase deficiency.
@nl
P356
P1476
Clinical manifestation of myeloperoxidase deficiency.
@en
P2093
P2888
P304
P356
10.1007/S001090050267
P577
1998-09-01T00:00:00Z
P6179
1029422868